Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
04/01/201922h05PR Newswire (US)Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch and Outlines Strategic Priorities ...NASDAQ:INSMInsmed Inc
04/12/201814h30GlobeNewswire Inc.Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INSMInsmed Inc
13/11/201822h06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INSMInsmed Inc
13/11/201819h15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INSMInsmed Inc
08/11/201822h09Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INSMInsmed Inc
08/11/201814h37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INSMInsmed Inc
08/11/201814h30GlobeNewswire Inc.Insmed Announces Changes to its Board of DirectorsNASDAQ:INSMInsmed Inc
06/11/201814h30GlobeNewswire Inc.Insmed to Present at Three November ConferencesNASDAQ:INSMInsmed Inc
30/10/201812h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INSMInsmed Inc
30/10/201812h30GlobeNewswire Inc.Insmed Reports Third Quarter 2018 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
23/10/201814h30GlobeNewswire Inc.Insmed to Host Third Quarter 2018 Financial Results Conference Call on Tuesday, October 30, 2018NASDAQ:INSMInsmed Inc
11/10/201814h30GlobeNewswire Inc.Insmed Presents New Data at IDWeek 2018 and CHEST Annual Meeting Enhancing the Understanding of MAC Lung Disease and Treatmen...NASDAQ:INSMInsmed Inc
04/10/201822h30GlobeNewswire Inc.Insmed Extends Patent Protection in Japan to 2033NASDAQ:INSMInsmed Inc
01/10/201814h00GlobeNewswire Inc.Insmed to Present at Two October ConferencesNASDAQ:INSMInsmed Inc
28/09/201823h58GlobeNewswire Inc.Insmed Announces FDA Approval of ARIKAYCE® (amikacin liposome inhalation suspension), the First and Only Therapy Specificall...NASDAQ:INSMInsmed Inc
17/09/201814h00GlobeNewswire Inc.Pivotal Phase 3 Data from CONVERT Study of ALIS in Patients with Treatment-Refractory NTM Lung Disease Caused by MAC Publishe...NASDAQ:INSMInsmed Inc
07/08/201823h30GlobeNewswire Inc.FDA Advisory Committee Votes 12-2 in Favor of the Safety and Effectiveness of Insmed’s ALIS for the Treatment of NTM Lung D...NASDAQ:INSMInsmed Inc
02/08/201813h30GlobeNewswire Inc.Insmed Reports Second Quarter 2018 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
26/07/201814h00GlobeNewswire Inc.Insmed to Host Second Quarter 2018 Financial Results Conference Call on Thursday, August 2, 2018NASDAQ:INSMInsmed Inc
15/06/201814h00GlobeNewswire Inc.Insmed Announces FDA Advisory Committee Meeting to Review ALIS as a treatment for NTM Lung Disease Caused by MACNASDAQ:INSMInsmed Inc
07/06/201814h00GlobeNewswire Inc.Insmed to Present at Three June ConferencesNASDAQ:INSMInsmed Inc
31/05/201822h27Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:INSMInsmed Inc
22/05/201823h15GlobeNewswire Inc.Insmed Announces Presentations at the American Thoracic Society 2018 International ConferenceNASDAQ:INSMInsmed Inc
17/05/201822h05GlobeNewswire Inc.Insmed Appoints Leo Lee to its Board of DirectorsNASDAQ:INSMInsmed Inc
16/05/201814h00GlobeNewswire Inc.Insmed Announces FDA Acceptance for Filing of New Drug Application for ALIS in NTM Lung Disease Caused by MACNASDAQ:INSMInsmed Inc
02/05/201815h21GlobeNewswire Inc.Insmed to Present at the Deutsche Bank 43rd Annual Health Care ConferenceNASDAQ:INSMInsmed Inc
02/05/201813h30GlobeNewswire Inc.Insmed Reports First Quarter 2018 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
25/04/201814h00GlobeNewswire Inc.Insmed to Host First Quarter 2018 Financial Results Conference Call on Wednesday, May 2, 2018NASDAQ:INSMInsmed Inc
05/04/201818h59Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INSMInsmed Inc
05/04/201818h57Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Dernières Valeurs Consultées

Delayed Upgrade Clock